CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe

CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technology platform. These transformational plans consist of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions designed and built according to the… Continue reading CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe

Revelation Pharma Announces Bi-coastal Expansion with Acquisitions of Taylors Pharmacy and Key Compounding

Revelation Pharma, a national network of 503A and 503B compounding pharmacies dedicated to providing “industry best” patient care and solutions, announced it has acquired Taylors Pharmacy, a thriving nationwide independent pharmacy based in Florida and licensed in over 41 states, and Washington-based Key Compounding Pharmacy, a staple in and around its Federal Way location. These strategic acquisitions mark the company’s continued… Continue reading Revelation Pharma Announces Bi-coastal Expansion with Acquisitions of Taylors Pharmacy and Key Compounding

CDI Labs Launches New VirScan, HuScan, and MouseScan Services for Massively Multiplexed Analysis of Serum Antibodies

CDI Labs Canada Inc., a leading provider of services for proteome wide antibody profiling and target identification, announced the launch of its VirScan®, HuScan®, and MouseScan™ services. These services utilize phage display immunoprecipitation sequencing (PhIP-Seq), a powerful method of multiplexed analysis that combines next-generation proteomics with high-throughput DNA sequencing, to provide researchers with unparalleled insights into the intricate… Continue reading CDI Labs Launches New VirScan, HuScan, and MouseScan Services for Massively Multiplexed Analysis of Serum Antibodies

Read Magazine’s Weekly News Roundup With Rocket Lab, SoundHound, Illumina, Gradiant, Xylem And More!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the nuances that follow the news. In Aerospace news this week… Rocket Lab Sets Launch Window For Next Capella Space Mission From Launch Complex 1 Rocket Lab USA, Inc, a global leader in launch… Continue reading Read Magazine’s Weekly News Roundup With Rocket Lab, SoundHound, Illumina, Gradiant, Xylem And More!

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

Renalytix plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces a collaboration with the Steno Diabetes Center (‘Steno’), Copenhagen, to advance translation of precision medicine solutions for patients with Diabetes and Chronic Kidney Disease (DKD). The initial focus… Continue reading Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

Remix Therapeutics Attains Near-Term Milestone from Roche Collaboration

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, announced that it has attained the near-term milestone as part of its collaboration and license agreement with Roche for the discovery and development of small molecule therapeutics that modulate RNA processing using Remix’s REMaster… Continue reading Remix Therapeutics Attains Near-Term Milestone from Roche Collaboration

Nusano and PharmaLogic Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals

Nusano Inc, a physics company transforming the production of medical radioisotopes, and PharmaLogic Holdings Corp., a leading radiopharmaceutical contract development and manufacturing organization (“CDMO”), announced a supply agreement to provide a more efficient and reliable supply of critical radioisotopes. The agreement will increase access to on-demand radioisotope supplies provided by Nusano for use in pharmaceutical… Continue reading Nusano and PharmaLogic Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals

Selkirk Pharma Appoints Colleen Dixon as New CEO

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, announced the appointment of Colleen Dixon as the company’s new Chief Executive Officer. Dixon, who formerly served as Vice President of Program Management at Selkirk Pharma, succeeds Patrick Haffey, the founder of… Continue reading Selkirk Pharma Appoints Colleen Dixon as New CEO

Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base

Illumina, Inc, a global leader in DNA sequencing and array-based technologies, announced that effective it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology. “The addition of Fluent BioSciences to Illumina will provide significant and new capabilities to our customers in a key growth area and advances our multiomics growth strategy,”… Continue reading Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base

Life Molecular Imaging and Jubilant Radiopharma announce Neuraceq availability in Mobile, AL

Life Molecular Imaging (LMI) and Jubilant Radiopharma, a global company that offers radiopharmaceuticals and radiopharmacies for nuclear medicine, announce the expansion of their strategic partnership and licensing agreement to provide and distribute Neuraceq® from Jubilant’s single photon emission computed tomography (SPECT) and Positron Emision Tomography (PET) radiopharmaceutical manufacturing site located in Mobile, AL. The first doses… Continue reading Life Molecular Imaging and Jubilant Radiopharma announce Neuraceq availability in Mobile, AL